VERU INC (Germany) Top Insiders
| FMW Stock | EUR 0.57 0.01 1.79% |
VERU INC employs about 233 people. The company is managed by 9 executives with a total tenure of roughly 63 years, averaging almost 7.0 years of service per executive, having 25.89 employees per reported executive. Examination of VERU INC's management performance can provide insight into the company performance.
| Charles Todd CEO Chief Executive Officer of The Female Health Company Division |
| Mitchell Steiner Chairman Chairman of the Board, President, Chief Executive Officer |
VERU |
VERU INC Management Team Effectiveness
The company has return on total asset (ROA) of (0.331) % which means that it has lost $0.331 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.7187) %, meaning that it generated substantial loss on money invested by shareholders. VERU INC's management efficiency ratios could be used to measure how well VERU INC manages its routine affairs as well as how well it operates its assets and liabilities.VERU INC Workforce Comparison
VERU INC DL 01 is one of the top stocks in number of employees category among its peers. The total workforce of Biotechnology industry is currently estimated at about 35,271. VERU INC maintains roughly 233 in number of employees contributing less than 1% to stocks in Biotechnology industry.
The company has Profit Margin (PM) of (2.13) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (2.11) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $2.11. VERU INC DL Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. VERU INC DL Price Series Summation is a cross summation of VERU INC price series and its benchmark/peer.
VERU INC Notable Stakeholders
A VERU INC stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as VERU INC often face trade-offs trying to please all of them. VERU INC's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting VERU INC's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Charles Todd | Chief Executive Officer of The Female Health Company Division | Profile | |
| Mitchell Steiner | Chairman of the Board, President, Chief Executive Officer | Profile | |
| Harry Fisch | Vice Chairman of the Board, Chief Corporate Officer | Profile | |
| Michele Greco | Chief Financial Officer, Chief Administrative Officer | Profile | |
| Mario Eisenberger | Independent Director | Profile | |
| Jesus Socorro | Independent Director | Profile | |
| K Barnette | Chief Scientific Officer | Profile | |
| Grace Hyun | Independent Director | Profile | |
| Michael Rankowitz | Independent Director | Profile |
About VERU INC Management Performance
The success or failure of an entity such as VERU INC DL often depends on how effective the management is. VERU INC management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of VERU management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the VERU management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. The company was formerly known as The Female Health Company and changed its name to Veru Inc. in July 2017. VERU INC operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 3 people.
VERU INC Workforce Analysis
Traditionally, organizations such as VERU INC use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare VERU INC within its industry.VERU INC Manpower Efficiency
Return on VERU INC Manpower
| Revenue Per Employee | 168.9K | |
| Revenue Per Executive | 4.4M | |
| Net Loss Per Employee | 2K | |
| Net Loss Per Executive | 52.9K |
Complementary Tools for VERU Stock analysis
When running VERU INC's price analysis, check to measure VERU INC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VERU INC is operating at the current time. Most of VERU INC's value examination focuses on studying past and present price action to predict the probability of VERU INC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VERU INC's price. Additionally, you may evaluate how the addition of VERU INC to your portfolios can decrease your overall portfolio volatility.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios |